Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep750 | Thyroid | ECE2021

Increasing levothyroxine requirements in a patient with previously stable hypothyroidism

Batool Maria , Cadogen Sinead , Kyaw Tun Tommy , Sreenan Seamus , Denton Mark , Mcdermott John

A 44 year old woman presented with leg swelling. Past history included hypothyroidism and ulcerative colitis treated with eltroxin (100 mg/day) and azathioprine (100 mg/day) respectively. Clinical examination revealed pitting oedema to knees and a ’puffy face’. Free T4 was 5.8 pmol/l (12–22 pmol/l), TSH 84.61 mU/l (0.27–4.20), serum albumin 24 g/l (40–49 g/l). She reported good compliance with L-thyroxine and no recent gastrointestinal symptoms. L-thyr...

ea0099p353 | Reproductive and Developmental Endocrinology | ECE2024

Renal 11β-hydroxysteroid dehydrogenase type 2 is of central importance for 11-oxygenated androgen biosynthesis and is disrupted in chronic kidney disease

Tomkins Maria , McDonnell Tara , Cussen Leanne , S Sagmeister Michael , Oestlund Imken , Shaheen Fozia , Harper Lorraine , S Hardy Rowan , E Taylor Angela , C Gilligan Lorna , Arlt Wiebke , McIlroy Marie , de Freitas Declan , Conlon Peter , Magee Colm , Denton Mark , O'Seaghdha Conall , Snoep Jacky , Heinz-Storbeck Karl , Sherlock Mark , W O'Reilly Michael

11-oxygenated androgens are a group of adrenal-derived C19 steroids that require activation in peripheral tissues. 11β-hydroxysteroid dehydrogenase type 2 (HSD11B2) has been shown in vitro to be essential for 11-oxygenated androgen activation, converting 11β-hydroxyandrostenedione (11OHA4) to 11-ketoandrostenedione (11KA4), the direct precursor of the potent androgen 11-ketotestosterone (11KT). As the kidney is the major site of HSD11B2 expression, we hypoth...